• CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies

    27 days ago - By San Diego Biotechnology

    SAN DIEGO, Dec. 21, 2021 - AXIM Biotechnologies, Inc (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19 diagnostics, oncological research, and dry eye disease, announced today that the Centers for Disease Control and Prevention highlighted a study that the Company...
    Read more ...